Marshall Wace’s Evotec EVO Stock Holding History

Marshall Wace’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,189	Closed	-$38K	–	3329
2026 Q1	$38K	Buy	15,189 +2,266	+18%	+$7.3K	﹤0.01%	3003
2025 Q4	$39.8K	Buy	+12,923	New	+$44.3K	﹤0.01%	2792
2025 Q3	–	Sell	-40,310	Closed	-$169K	–	3013
2025 Q2	$169K	Buy	+40,310	New	+$158K	﹤0.01%	2481
2022 Q1	–	Sell	-16,272	Closed	-$387K	–	3524
2021 Q4	$387K	Buy	+16,272	New	+$379K	﹤0.01%	2932

Other funds holding EVO

DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

Marshall Wace's EVO Position: Q2 2026 in Review

Marshall Wace sold out of Evotec (EVO) in Q2 2026, closing a stake of 15,189 shares — an estimated $38K sold.

Marshall Wace first reported a position in EVO in Q4 2021 and held it in 4 quarters. The position peaked at $387K in Q4 2021. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

Marshall Wace reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
Marshall Wace sold 15,189 Evotec shares in Q2 2026, an estimated $38K.
Marshall Wace first reported a position in Evotec in Q4 2021 and held it in 4 quarters.
Marshall Wace's Evotec position peaked at $387K in Q4 2021.
34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.